The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its footprint in the country amid President Trump’s tariff threats.

Roche announced a $50 billion investment in the U.S. over the next five years, according to CNBC. The move aims to expand its manufacturing and R&D footprint amid tariff threats from President Donald Trump.

With the threat of pharmaceutical tariffs hanging over the biopharmaceutical industry, Roche is the latest addition to a growing list of major drugmakers that are bolstering their manufacturing foo | The Swiss pharma's sweeping $50 billion investment comes as the threat of U.